BIOMAT Database Logo BIOMAT Database Logo

Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential. 1999

F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Laboratoire de Recherche en Dermatologie, CNRS UPRESA 6021, IFR-53 Biomolécules, Faculté de Médecine, Reims, France.

The production of various proteolytic enzymes by tumor cells facilitate the invasion of solid tumors into surrounding tissues. We examined three cell lines (M1Dor, M4Be and M3Da) derived from malignant melanoma which exhibited different abilities to grow in nude mice following subcutaneous grafting. By in vitro invasion assay using Boyden-chambers technique, we found that none of those cell lines were able to invade the Matrigel. Several studies have substantiated the role of matrix metalloproteinases (MMP), mainly gelatinases MMP-9 and MMP-2, in melanoma cell invasion. Each cell line constitutively produced MMP-2 (but not MMP-9) in its latent form only, with stronger production for the most tumorigenic cell line in vivo (M3Da). Integrity of the MMP-2 activation process was studied since MMP-2 was also recovered as zymogen at the cell plasma membrane. All cell lines secreted TIMP-1 and TIMP-2 in a constitutive manner and again, but TIMP-2 production as well as MT1-MMP expression were found inversely related to their tumorigenic potential. Plating cells onto type I or type IV collagen did not trigger pro-MMP-2 activation; on the contrary, conversion of pro-MMP-2 to its active form could be evidenced when melanoma cell lines were seeded in a three dimensional type I collagen lattice.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015152 Blotting, Northern Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Northern Blotting,Blot, Northern,Northern Blot,Blots, Northern,Blottings, Northern,Northern Blots,Northern Blottings
D053504 Matrix Metalloproteinases, Membrane-Associated Matrix metalloproteinases that are associated with the CELL MEMBRANE, either through transmembrane domains or GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS. Membrane-type matrix metalloproteinases may act within the pericellular environment to influence the process of CELL MIGRATION. Membrane-Type Matrix Metalloproteinase,MT-MMP Enzymes,Matrix Metalloproteinase, Membrane-Type,Membrane-Type Matrix Metalloproteinases,MT MMP Enzymes,Matrix Metalloproteinase, Membrane Type,Matrix Metalloproteinases, Membrane Associated,Matrix Metalloproteinases, Membrane-Type,Membrane Type Matrix Metalloproteinase,Membrane Type Matrix Metalloproteinases,Membrane-Associated Matrix Metalloproteinases,Metalloproteinase, Membrane-Type Matrix,Metalloproteinases, Membrane-Associated Matrix,Metalloproteinases, Membrane-Type Matrix

Related Publications

F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Expression of cell surface glycoproteins in human melanoma cell lines with different tumorigenic properties.
October 1985, International journal of cancer,
F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines.
March 2013, Laboratory investigation; a journal of technical methods and pathology,
F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Expression and release of interleukin-1 by different human melanoma cell lines.
January 1989, Journal of the National Cancer Institute,
F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Expression of laminin in metastatic melanoma cell lines with different metastatic potential.
January 2001, Anticancer research,
F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Human melanoma cell lines deficient in GD3 ganglioside expression exhibit altered growth and tumorigenic characteristics.
October 1996, The Journal of investigative dermatology,
F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A).
May 2007, The Biochemical journal,
F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Inhibitors of lymphocyte activation secreted by human melanoma cell lines.
January 1990, Medical oncology and tumor pharmacotherapy,
F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Ia-like antigen expression on biologically different human melanoma cell lines.
May 1984, European journal of cancer & clinical oncology,
F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity.
April 1995, International journal of cancer,
F Capon, and H Emonard, and W Hornebeck, and F X Maquart, and P Bernard
Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential.
January 2004, Pathobiology : journal of immunopathology, molecular and cellular biology,
Copied contents to your clipboard!